Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway
Abstract
Background/objectives It has been reported that irisin regulated exercise-mediated adipocyte browning; however, the systematical effects of irisin on the metabolism of glucose and lipid in diabetes are largely unknown. In the present study, we investigated the role and underlying mechanism of irisin in glucose utilization and lipid metabolism in diabetic mice.Methods A mouse model of diabetes was established by feeding C57BL/6 mice with high-fat diet. The diabetic mice were then treated with irisin. To mimic type 2 diabetes in vitro, myocytes and hepatocytes were cultured in a medium of high glucose and high fat. Glucose uptake, fatty acid oxidation and the expression of related protein were evaluated.Results Irisin improved glucose tolerance and glucose uptake as evidenced by increased (18)F-FDG accumulation and GLUT4 translocation in diabetic skeletal muscle. Irisin also increased glucose uptake in myocytes cultured in high glucose/high fatty acid medium. In contrast, irisin reduced the expression of PEPCK and G6Pase, which are involved in gluconeogenesis, in diabetic liver. Consistently, irisin reduced fat weight and serum total cholesterol and triglyceride levels in diabetic mice, but increased acetyl coenzyme A carboxylase-β phosphorylation in muscle tissue and uncoupling protein 1 expression in fat tissue. In addition, irisin increased the oxidation of fatty acid in myocytes. Knockdown of the adenosine monophosphate (AMP)-activated protein kinase (AMPK) attenuated the effects of irisin on glucose uptake and fatty acid β-oxidation in myocytes. Similarly, inhibition of AMPK by a specific inhibitor reduced the effects of irisin on PEPCK and G6Pase expression in hepatocytes.Conclusions Our results suggest that irisin has an essential role in glucose utilization and lipid metabolism, and irisin is a promising pharmacological target for the treatment of diabetes and its complications.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In skeletal muscle after physical activity, irisin induces downstream activation of glucose and free fatty acid uptake and oxidation.
“In SkM, after physical activity, irisin induced downstream activation of glucose and FFA uptake and oxidation [62].”
Exercise-inducible myokines irisin, IL-6, IL-15, BAIBA, and METRNL, as well as osteokine OCN, directly stimulate oxidative metabolism in autocrine and endocrine ways.
“Exercise-inducible myokines, such as irisin [62,63], IL-6 [76,77], IL-15 [91,126], BAIBA [111], and METRNL [100], as well as the osteokine OCN [71] have been shown to directly stimulate oxidative metabolism in autocrine and endocrine ways, respectively (1).”
Other studies have reported effects of irisin on body fat reduction through mechanisms other than UCP-1, such as improved glucose tolerance and lipid oxidation via phosphorylation of AMPK and acetyl-CoA-carboxylase.
“Other studies have reported effects of irisin on body fat reduction through other mechanisms, such as improved glucose tolerance and lipid oxidation via phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA-carboxylase [52, 53].”
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · see citing works
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856 · see citing works
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · see citing works
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,283 · see citing works
THE AMP-ACTIVATED/SNF1 PROTEIN KINASE SUBFAMILY: Metabolic Sensors of the Eukaryotic Cell?
Hardie, D. G., Carling, D., & Carlson, M. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.821 · Cited by 1,436 · see citing works
Petrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., & Nedergaard, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053942 · Cited by 1,263 · see citing works
The AMP-activated protein kinase cascade – a unifying system for energy control
Carling, D. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.005 · Cited by 1,112 · see citing works
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040 · see citing works
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,028 · see citing works
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,027 · see citing works
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes
Winder, W. W., & Hardie, D. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e1 · Cited by 1,000 · see citing works
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903 · see citing works
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · see citing works
Moreno-Navarrete, J. M., Ortega, F., Serrano, M., Guerra, E., Pardo, G., Tinahones, F., Ricart, W., & Fernández-Real, J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2749 · Cited by 788 · see citing works
Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., et al. (2014) · Diabetes · doi:10.2337/db13-1106 · Cited by 733 · see citing works
He, J., Watkins, S., & Kelley, D. E. (2001) · Diabetes · doi:10.2337/diabetes.50.4.817 · Cited by 518 · see citing works
DeFronzo, R. A., Ferrannini, E., & Simonson, D. C. (1989) · Metabolism · doi:10.1016/0026-0495(89)90129-7 · Cited by 515 · see citing works
Simoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441 · see citing works
Serum irisin levels in new-onset type 2 diabetes
Choi, Y., Kim, M. K., Bae, K.-H., Seo, H.-A., Jeong, J.-Y., Lee, W.-K., Kim, J., Lee, I., & Park, K. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.007 · Cited by 422 · see citing works
Lochhead, P. A., Salt, I. P., Walker, K. S., Hardie, D. G., & Sutherland, C. D. (2000) · Diabetes · doi:10.2337/diabetes.49.6.896 · Cited by 391 · see citing works
Foretz, M., Ancellin, N., Andréelli, F., Saintillan, Y., Grondin, P., Kahn, A., Thorens, B., Vaulont, S., & Viollet, B. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1331 · Cited by 389 · see citing works
Huh, J. Y., Mougios, V., Kabasakalis, A., Fatouros, I., Siopi, A., Douroudos, I. I., Filippaios, A., Panagiotou, G., Park, K. H., & Mantzoros, C. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1437 · Cited by 363 · see citing works
Ishibashi, J., & Seale, P. (2010) · Science · doi:10.1126/science.1190816 · Cited by 344 · see citing works
Gastaldelli, A., Baldi, S., Pettiti, M., Toschi, E., Camastra, S., Natali, A., Landau, B. R., & Ferrannini, E. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1367 · Cited by 320 · see citing works
Valera, A., Pujol, A., Pelegrín, M., & Bosch, F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9151 · Cited by 297 · see citing works
Woods, A., Salt, I. P., Scott, J., Hardie, D. G., & Carling, D. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01209-4 · Cited by 261 · see citing works
Koistinen, H. A., Galuska, D., Chibalin, A., Yang, J., Zierath, J. R., Holman, G. D., & Wallberg‐Henriksson, H. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1066 · Cited by 231 · see citing works
Wang, D., Luo, P., Wang, Y., Li, W., Wang, C., Sun, D., Zhang, R., Su, T., Ma, X., Zeng, C., et al. (2013) · Diabetes · doi:10.2337/db12-1025 · Cited by 179 · see citing works
Glucose Regulates in Vivo Glucose-6-phosphatase Gene Expression in the Liver of Diabetic Rats
Massillon, D., Barzilai, N., Chen, W., Hu, M., & Rossetti, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9871 · Cited by 168 · see citing works
Barzilai, N., & Rossetti, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74566-9 · Cited by 162 · see citing works
Shih, C., Lin, C., Lin, W., & Wu, J. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.02.039 · Cited by 136 · see citing works
Kim, E. J., Jung, S., Son, K. H., Kim, S. R., Ha, T. Y., Park, M. G., Jo, I. G., Park, J. G., Choe, W., Kim, S. S., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034447 · Cited by 122 · see citing works
Lian, K., Du, C., Liu, Y., Zhu, D., Yan, W., Zhang, H., Hong, Z., Liu, P., Zhang, L., Pei, H., et al. (2014) · Diabetes · doi:10.2337/db14-0312 · Cited by 119 · see citing works
Glucose-6-Phosphatase Structure, Regulation, and Function: An Update
Foster, J. D., Pederson, B. A., & Nordlie, R. C. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-215-44142 · Cited by 105 · see citing works
Dombrowski, L., Roy, D., Marcotte, B., & Marette, A. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.4.e667 · Cited by 87 · see citing works
Swick, A. G., Orena, S., & O’Connor, A. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.012 · Cited by 84 · see citing works
Evidence of Increased Systemic Glucose Production and Gluconeogenesis in an Early Stage of NIDDM
Perriello, G., Pampanelli, S., Sindaco, P., Lalli, C., Ciofetta, M., Volpi, E., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1997) · Diabetes · doi:10.2337/diab.46.6.1010 · Cited by 83 · see citing works
Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats
Roberts, M. D., Bayless, D. S., Jenkins, N. T., Padilla, J., Childs, T. E., Martin, J. S., Dalbo, V. J., Booth, F. W., Rector, R. S., & Laughlin, M. H. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.002 · Cited by 73 · see citing works
Yki‐Järvinen, H. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-415 · Cited by 70 · see citing works
Rosella, G., Zajac, J. D., Baker, L., Kaczmarczyk, S. J., Andrikopoulos, S., Adams, T. E., & Proietto, J. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.10.8544847 · Cited by 56 · see citing works
Li, H., Song, Y., Zhang, L., Gu, Y., Li, F., Pan, S., Jiang, L., Liu, F., Ye, J., & Li, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036712 · Cited by 46 · see citing works
Park, J. H., Kaushansky, K., & Levitt, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53253-1 · Cited by 37 · see citing works
TNFα Decreases Gluconeogenesis in Hepatocytes Isolated from 10-Day-Old Rats
Gotō, M., Yoshioka, T., Battelino, T., Ravindranath, T. M., & Zeller, W. P. (2001) · Pediatric Research · doi:10.1203/00006450-200104000-00018 · Cited by 28 · see citing works
Gluconeogenesis in Type 2 Diabetes
Gerich, J. E., & Nurjhan, N. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2910-1_18 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · see citing works
Physiology and role of irisin in glucose homeostasis
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.221 · Cited by 621 · see citing works
Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases
Demine, S., Renard, P., & Arnould, T. (2019) · Cells · doi:10.3390/cells8080795 · Cited by 476 · see citing works
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
Cheng, C., Ku, H., & Lin, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113447 · Cited by 434 · see citing works
Role of free fatty acids in endothelial dysfunction
Ghosh, A., Gao, L., Thakur, A., Siu, P. M., & Lai, C. W. K. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0357-5 · Cited by 418 · see citing works
“However, patients with obesity or T2DM show higher levels of FFAs that lead to insulin resistance [4], which further contributes to ED, a pivotal step in the initiation and progression of atherosclerosis [148].”
BackgroundInfluentialGonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278 · see citing works
“Exercise-inducible myokines, such as irisin [62,63], IL-6 [76,77], IL-15 [91,126], BAIBA [111], and METRNL [100], as well as the osteokine OCN [71] have been shown to directly stimulate oxidative metabolism in autocrine and endocrine ways, respectively (1).”
BackgroundPolyzos, S. A., Anastasilakis, A. D., Efstathiadou, Z. A., Makras, P., Perakakis, N., Kountouras, J., & Mantzoros, C. S. (2018) · Endocrine · doi:10.1007/s12020-017-1476-1 · Cited by 262 · see citing works
The role of exercise-induced myokines in regulating metabolism
Huh, J. Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0994-y · Cited by 242 · see citing works
“In the liver, irisin stimulates glycogenesis while it reduces gluconeogenesis and lipogenesis through regulat- ing GSK3, FOXO1, and SREBP2 (Liu et al. 2015; Xin et al. 2015; Tang et al. 2016).”
BackgroundLi, X., Jamal, M., Guo, P., Jin, Z. Y., Zheng, F., Song, X., Zhan, J., & Wu, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109363 · Cited by 196 · see citing works
Sharma, A., Anand, S. K., Singh, N., Dwivedi, U. N., & Kakkar, P. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113614 · Cited by 197 · see citing works
Role of irisin in physiology and pathology
Liu, S., Cui, F., Ning, K., Wang, Z., Fu, P., Wang, D., & Xu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962968 · Cited by 171 · see citing works
“Long-term exercise-induced irisin or supplementation of exogenous r-irisin could protect the liver from non-alcoholic fatty liver disease (NAFLD) (6, 7), liver glucose disorder (29, 30), or I/R-induced liver injury (31), which embodied the potential role of irisin in muscle-liver crosstalk (32).”
BackgroundChang, J. S., Kim, T. H., Nguyen, T. T., Park, K., Kim, N., & Kong, I. D. (2017) · Geriatrics & Gerontology International · doi:10.1111/ggi.13030 · Cited by 166 · see citing works
Myokines mediate the cross talk between skeletal muscle and other organs
Chen, W., Wang, L., You, W., & Shan, T. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30033 · Cited by 162 · see citing works
“Irisin has been regarded as an important myokine in the liver metabolic pathway (Xin et al., 2016).”
BackgroundRoles of myokines in exercise-induced improvement of neuropsychiatric function
Kim, S., Choi, J., Moon, S., Park, D., Kwak, H., & Kang, J. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02253-8 · Cited by 168 · see citing works
Administration of Lactobacillus paracasei ameliorates type 2 diabetes in mice
Dang, F., Jiang, Y., Pan, R., Zhou, Y., Wu, S. L., Wang, R., Zhuang, K., Zhang, W., Li, T., & Man, C. (2018) · Food & Function · doi:10.1039/c8fo00081f · Cited by 148 · see citing works
Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice
Geisler, C. E., Hepler, C., Higgins, M. R., & Renquist, B. J. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0122-x · Cited by 138 · see citing works
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
Park, M., & Choi, K. M. (2023) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2023.155577 · Cited by 106 · see citing works
Pignataro, P., Dicarlo, M., Zerlotin, R., Zecca, C., Dell’Abate, M. T., Buccoliero, C., Logroscino, G., Colucci, S. C., & Grano, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041605 · Cited by 131 · see citing works
“skeletal muscles [11,19], increases hepatic glucose and lipid metabolism [20,21], displaying beneficial effects on metabolic disorders, such as diabetes [11,22].”
BackgroundMechanisms by Which Skeletal Muscle Myokines Ameliorate Insulin Resistance
Balakrishnan, R., & Thurmond, D. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094636 · Cited by 132 · see citing works
“Irisin Adipose tissue, Brain, Bone, Heart, Blood, Kidney ↑Glucose uptake [64,189] ↑ β-oxidation and mitochondrial biogenesis [63,189]”
BackgroundBone and Muscle Crosstalk in Aging
He, C., He, W., Hou, J., Chen, K., Huang, M., Yang, M., Luo, X., & Li, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.585644 · Cited by 128 · see citing works
Protective actions of exercise-related FNDC5/irisin in memory and Alzheimer's disease
de Freitas, G. B., Lourenco, M. V., & De Felice, F. G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15039 · Cited by 120 · see citing works
Shao, L., Li, H., Chen, J., Song, H., Zhang, Y., Wu, F., Wang, W., Zhang, W., Wang, F., Li, H., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.084 · Cited by 118 · see citing works
Interleukin-15 facilitates muscle regeneration through modulation of fibro/adipogenic progenitors
Kang, X., Yang, M., Shi, Y., Xie, M., Zhu, M. P., Zheng, X., Zhang, C., Ge, Z., Bian, X., Lv, J.-T., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0251-0 · Cited by 117 · see citing works
Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2
Zhu, W., Sahar, N.-E., Javaid, H. M. A., Pak, E. S., Liang, G., Wang, Y., Ha, H., & Huh, J. Y. (2021) · Cells · doi:10.3390/cells10123306 · Cited by 116 · see citing works
“Irisin ameliorated endoplasmic reticulum (ER) stress and liver fibrosis in hepatic stellate cells [45], regulated cholesterol homeostasis [46,47], and improved fatty acid oxidation and glucose metabolism in mice [22,48].”
BackgroundFNDC5/Irisin inhibits pathological cardiac hypertrophy
Yu, Q., Kou, W., Xu, X., Zhou, S., Luan, P., Xu, X., Li, H., Zhuang, J., Wang, J., Zhao, Y., et al. (2019) · Clinical Science · doi:10.1042/cs20190016 · Cited by 115 · see citing works
An update on the role of irisin in the regulation of endocrine and metabolic functions
Mahgoub, M., D’Souza, C. M., Darmaki, R. S. A., Baniyas, M. M. Y. H., & Adeghate, E. A. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.018 · Cited by 109 · see citing works
Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism
Wang, S., & Pan, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.047 · Cited by 107 · see citing works
Irisin, a fascinating field in our times
Bao, J., She, Q.-Y., Hu, P., Jia, N., & Li, A. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.06.003 · Cited by 102 · see citing works
Lin, C., Guo, Y., Xia, Y., Li, C., Xu, X., Qi, T., Zhang, F., Fan, M., Hu, G., Zhao, H., et al. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.06.013 · Cited by 100 · see citing works
Research progress in the role and mechanism of Leucine in regulating animal growth and development
Rehman, S. U., Ali, R., Zhang, H., Zafar, M. H., & Wang, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1252089 · Cited by 97 · see citing works
“Coenzyme inactivity Carboxylase activity activates AMPK, which boosts fat oxidation, lowers glucose generation, affects cholesterol and total triglyceride formation, disrupts mTOR signaling, and inhibits lipogenesis (Xin et al., 2016).”
BackgroundGuo, P., Jin, Z. Y., Wu, H., Li, X., Ke, J., Zhang, Z., & Zhao, Q. (2019) · Brain and Behavior · doi:10.1002/brb3.1425 · Cited by 92 · see citing works
Pal, S. C., & Méndez‐Sánchez, N. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i25.3999 · Cited by 91 · see citing works
Shao, L., Meng, D., Yang, F., Song, H., & Tang, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.020 · Cited by 90 · see citing works
The Role of Irisin in Alzheimer’s Disease
Kim, O. Y., & Song, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110407 · Cited by 90 · see citing works
“Irisin decreases the expression of G6Pase and PEPCK, both of which are critical for gluconeogenesis, in the liver [66].”
BackgroundBi, J., Zhang, J., Ren, Y., Du, Z., Zhang, Y., Liu, C., Wang, Y., Zhang, L., Shi, Z., Wu, Z., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136277 · Cited by 88 · see citing works
“Interestingly, several studies have reported that the regulatory role of irisin in energy metabolism is associated with activation of AMPK (15, 29).”
BackgroundSarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Guo, A., Li, K., & Xiao, Q. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111022 · Cited by 83 · see citing works
Carson, B. P. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00097 · Cited by 83 · see citing works
“Irisin treatment of myocytes also elevated FA oxidation suggesting a protective effect against progression of T2D (75).”
BackgroundSo, W. Y., & Leung, P. S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.022 · Cited by 83 · see citing works
Faienza, M. F., Brunetti, G., Sanesi, L., Colaianni, G., Celi, M., Piacente, L., D’Amato, G., Schipani, E., Colucci, S. C., & Grano, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.046 · Cited by 82 · see citing works
Shen, S., Liao, Q., Zhang, T., Pan, R., & Lin, L. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14802 · Cited by 86 · see citing works
“Treatment with irisin increases mitochondrial oxidative metabolism, mitochondrial uncoupling, and fatty acid oxidation in skeletal muscle (Xin et al., 2016).”
BackgroundMetwally, M., Bayoumi, A., Romero‐Gómez, M., Thabet, K., John, M., Adams, L. A., Huo, X., Aller, R., García‐Monzón, C., Arias, M., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.021 · Cited by 81 · see citing works
“This data is supported by animal studies that FNDC5 improves hepatic steatosis, protects mice against genetic- and diet-induced obesity, and improves hepatic and peripheral insulin resistance via regulating AMPK signaling in myocytes and hepatocytes [34, 36-38].”
ResultTu, W., Qiu, H., Liu, Q., Li, X., Zhao, J.-Z., & Zeng, X. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1177-6 · Cited by 79 · see citing works
“Accumulating evidence has demonstrated that irisin contributes to the regulation of glucose and lipid metabolism in the skeletal muscle and adipose tissue [7, 8].”
BackgroundPhysical Exercise-Induced Myokines in Neurodegenerative Diseases
Lee, B., Shin, M., Park, Y., Won, S.-Y., & Cho, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115795 · Cited by 79 · see citing works
The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
Chang, C. L., Huang, S. Y., Hsu, Y. C., Chin, T. H., & Soong, Y. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42061-9 · Cited by 76 · see citing works
Ruan, Q., Huang, Y., Yang, L., Ruan, J., Gu, W., Zhang, X., Zhang, Y., Zhang, W., & Yu, Z. (2019) · Peptides · doi:10.1016/j.peptides.2019.01.004 · Cited by 76 · see citing works
Winn, N. C., Grunewald, Z. I., Liu, Y., Heden, T. D., Nyhoff, L. M., & Kanaley, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170690 · Cited by 69 · see citing works
Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke
Tu, W., Qiu, H., Cao, J., Liu, Q., Zeng, X., & Zhao, J.-Z. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0651-2 · Cited by 67 · see citing works
Zhang, D., Xie, T., & Leung, P. S. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495395 · Cited by 65 · see citing works
Adipose–Muscle Crosstalk in Age-Related Metabolic Disorders: The Emerging Roles of Adipo-Myokines
Fang, P., She, Y., Yu, M., Min, W., Shang, W., & Zhang, Z. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101829 · Cited by 62 · see citing works
The Role of Irisin in Cancer Disease
Pinkowska, A., Podhorska‐Okołów, M., Dzięgiel, P., & Nowińska, K. (2021) · Cells · doi:10.3390/cells10061479 · Cited by 61 · see citing works
“Ir enhanced glucose utilization by increasing 5’AMP-activated protein kinase (AMPK) phosphorylation in myocytes and hepatocytes of diabetic mice in in vitro and in vivo studies [54].”
BackgroundAdipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
Senesi, P., Luzi, L., & Terruzzi, I. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218372 · Cited by 61 · see citing works
“Further, irisin plays an important role in hepatic metabolism reducing lipogenesis and gluconeogenesis and increasing lipid oxidation and glycolysis [137,138].”
BackgroundXin, C., Zhang, Z., Gao, G., Ding, L., Yang, C., Wang, C.-Z., Liu, Y.-J., Guo, Y.-F., Yang, X.-Q., Zhang, L.-J., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565160 · Cited by 52 · see citing works
“Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway (Xin et al., 2016).”
BackgroundYano, N., Zhang, L. X., Wei, D., Dubielecka, P., Wei, L., Zhuang, S., Zhu, P., Qin, G., Liu, P., Chin, Y., et al. (2020) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00219.2019 · Cited by 53 · see citing works
Irisin and Autophagy: First Update
Pesce, M., Ballerini, P., Paolucci, T., Puca, I., Farzaei, M. H., & Patruno, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207587 · Cited by 59 · see citing works
Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56 · see citing works
“In particular, irisin improves glucose uptake [55,188,192–194] and inhibits gluconeogenesis and glycogenolysis [194], while increasing glycogen storage [188,194] and stimulating FAs oxidation [55,194,195].”
BackgroundAmengual, J., García‐Carrizo, F., Arreguín, A., Mušinović, H., Granados, N., Palou, A., Bonet, M. L., & Ribot, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488422 · Cited by 56 · see citing works
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58 · see citing works
“Phosphorylation of AMPK α / insulin receptor β -subunit/ERK1/2 also contributes to the regulation of these effects, which is maintained by irisin [96, 97].”
Irisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities
Trettel, C. D. S., Pelozin, B. R. D. A., Barros, M. P., Bachi, A. L. L., Braga, P. G. S., Momesso, C. M., Furtado, G. E., Valente, P. A., de Oliveira, E. M., Hogervorst, E., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1106529 · Cited by 55 · see citing works
“In a previous study, hepatic-released irisin was demonstrated to function as a paracrine/autocrine factor that inhibits lipogenesis and gluconeogenesis via the adenosine 5’-monophosphate (AMP)activated protein kinase pathway by reducing the expression of phosphoenolpyruvate carboxyinase (Pepck) and glucose-6phosphate…”
BackgroundSerum levels of irisin predict short-term outcomes in ischemic stroke
Wu, H., Guo, P., Jin, Z. Y., Li, X., Yang, X., Tang, C., Wang, Y., & Ke, J. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.017 · Cited by 55 · see citing works
Biondi, G., Marrano, N., Borrelli, A., Rella, M., Palma, G., CALDERONI, I., Siciliano, E., Lops, P., Giorgino, F., & Natalicchio, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105522 · Cited by 54 · see citing works
High Serum Irisin Level as an Independent Predictor of Diabetes Mellitus
Huh, J. H., Ahn, S. V., Choi, J. H., Koh, S. B., & Chung, C. H. (2016) · Medicine · doi:10.1097/md.0000000000003742 · Cited by 51 · see citing works
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46 · see citing works
PARP10 (ARTD10) modulates mitochondrial function
Márton, J., Fodor, T., Nagy, L., Vida, A., Kis, G. N., Brunyánszki, A., Antal, M., Lüscher, B., & Bai, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0187789 · Cited by 49 · see citing works
“In fact, AMPK activation has been shown to enhance fatty acid oxidation [31, 51, 52] that makes it tempting to speculate that PARP10-induced AMPK activation may stand behind enhanced fatty acid oxidation.”
BackgroundThe Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48 · see citing works
“Another key signaling pathway is represented by the AMPactivated kinase (AMPK), that promotes glucose and FFA uptake/metabolism and modulates long-term responses in mitochondria, by interacting with peroxisome proliferator receptor gamma activator 1a (PGC-1a) (14).”
BackgroundInfluentialIrisin Acts via the PGC-1α and BDNF Pathway to Improve Depression-like Behavior
Jo, D., & Song, J. (2021) · Clinical Nutrition Research · doi:10.7762/cnr.2021.10.4.292 · Cited by 48 · see citing works
“It is found in various organs including the brain, heart, liver, and skeletal muscles [34], and has been reported to control glucose metabolism, lipid metabolism, and energy homeostasis in skeletal muscle and adipose tissues [35-37].”
BackgroundIrisin ameliorates high glucose‐induced cardiomyocytes injury via AMPK/mTOR signal pathway
Deng, J., Zhang, N., Chen, F., Yang, C., Ning, H., Xiao, C. Y., Sun, K., Liu, Y., Yang, M., Hu, T., et al. (2020) · Cell Biology International · doi:10.1002/cbin.11441 · Cited by 48 · see citing works
“which was reversed by irisin to some extent, which was consistent with the previous study (Xin et al., 2016).”
ResultAbdou, H. M., Hamaad, F. A., Ali, E. Y., & Ghoneum, M. H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112838 · Cited by 47 · see citing works
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46 · see citing works
Secretomics to Discover Regulators in Diseases
Song, P., Kwon, Y., Joo, J., Kim, D.-G., & Yoon, J. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163893 · Cited by 45 · see citing works
“In vivo, administration of irisin to high-fat diet (HFD)-fed mice decreased the fasting blood glucose level, and improved glucose and insulin tolerance; the same effects were detected in obese and HFD-fed mice with FNDC5 overexpression [95].”
BackgroundThe Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis
Yano, N., Zhao, Y., & Zhao, T. C. (2021) · Endocrines · doi:10.3390/endocrines2030025 · Cited by 46 · see citing works
“Similarly, the enhanced uptake of glucose in the C2C12 cells treated with irisin and cultured in high ambient glucose and PA containing medium were alleviated after the inhibition of the AMPK signaling with AMPKα2 siRNA [62].”
BackgroundHu, Y. W., Zhou, Y., Yang, Y., Tang, H., Si, Y., Chen, Z., Shi, Y., & Fang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.832707 · Cited by 44 · see citing works
“Collectively, the findings provide the explanation for the increased oxidative stress and neuronal apoptosis under high glucose conditions (Fossati et al., 2016; Xu et al., 2016).”
BackgroundButt, Z. D., Hackett, J. D., & Volkoff, H. (2017) · Peptides · doi:10.1016/j.peptides.2017.02.003 · Cited by 44 · see citing works
Pang, Y.-L., Zhu, H., Xu, J., Yang, L., Liu, L., & Li, J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.006 · Cited by 35 · see citing works
Kolodziejski, P. A., Pruszyńska‐Oszmałek, E., Wojciechowicz, T., Sassek, M., Leciejewska, N., Jasaszwili, M., Billert, M., Małek, E., Szczepankiewicz, D., Misiewicz-Mielnik, M., et al. (2021) · Genes · doi:10.3390/genes12050756 · Cited by 43 · see citing works
“It was shown that irisin increases fatty acid β-oxidation in muscle tissue [77].”
BackgroundWu, X., Li, X., Dang, Z., & Jia, Y. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26681 · Cited by 42 · see citing works
“pylori-infected mice with chronic gastritis mice was established, as described previously.(18,19) Briefly, male C57Bl/6 mice (4 weeks old, 19-21 g) were purchased from Henan Province Hospital of TCM.”
MethodLi, L., Wang, Y., Zeng, X., Hu, Y. M., Zhang, J., Wang, B., & Chen, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136186 · Cited by 41 · see citing works
The role of irisin in metabolic flexibility: beyond adipose tissue browning.
Shen, S.-N., Liao, Q., Chen, X.-P., Peng, C., & Lin, L.-G. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.03.019 · Cited by 36 · see citing works
Yang, X.-Y., Tse, M. C. L., Hu, X., Jia, W.-H., Du, G., & Chan, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494655 · Cited by 33 · see citing works
Irisin at the crossroads of inter-organ communications: Challenge and implications
Zhao, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.989135 · Cited by 40 · see citing works
“Additionally, in diabetic obese C57BL/6 mice, the injection of r-irisin (0.5 µg/g body weight) caused a reduction in Pepck and G6pase expressions in the liver by stimulating the AMPK signaling pathway, and blocking of AMPK signaling decreased the influence of irisin on hepatocytic expressions of Pepck and G6pase (86).”
BackgroundInfluentialIrisin is a biomarker for metabolic syndrome in prepubertal children
Shim, Y. S., Kang, M. J., Yang, S., & Hwang, I. T. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0260 · Cited by 37 · see citing works
Juszczak, F., Vlassembrouck, M., Botton, O., Zwakhals, T., Decarnoncle, M., Tassin, A., Caron, N., & Declèves, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010350 · Cited by 35 · see citing works
“Interestingly, inhibition of AMPK by a specific inhibitor reduced the effects of Irisin in myocytes and hepatocytes, suggesting that Irisin could be implicated in AMPK pathway regulation [72].”
BackgroundMechanism of CNS regulation by irisin, a multifunctional protein
Qi, J., Yang, L.-K., Wang, X., Wang, M., Li, X., Feng, B., Wu, Y., Liu, S., & Zhang, K. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.007 · Cited by 36 · see citing works
Llanos, P., & Palomero, J. (2022) · Cells · doi:10.3390/cells11244008 · Cited by 37 · see citing works
Irisin regulates cardiac physiology in zebrafish
Sundarrajan, L., Yeung, C., Hahn, L., Weber, L. P., & Unniappan, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181461 · Cited by 35 · see citing works
Relation of serum irisin level with metabolic and antropometric parameters in obese children
Çatlı, G., Küme, T., Tuhan, H., Anık, A., Çalan, Ö. G., Böber, E., & Abacı, A. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.019 · Cited by 34 · see citing works
Increased FNDC5 is associated with insulin resistance in high fat‐fed mice
Guilford, B. L., Parson, J. C., Grote, C., Vick, S. N., Ryals, J. M., & Wright, D. (2017) · Physiological Reports · doi:10.14814/phy2.13319 · Cited by 35 · see citing works
“Our results are congruent with previous reports in both animals and humans that suggest the PGC-1aFNDC5/irisin pathway is upregulated in response to chronically elevated blood glucose as well as HOMA-IR (Huh et al. 2012; Kleiner et al. 2012; Crujeiras et al. 2014; Keuper et al. 2014; Yang et al. 2015; Xin et al. 2016;…”
BackgroundResultInfluentialLi, B., Yao, Q., Guo, S., Ma, S., Dong, Y., Xin, H., Wang, H., Liu, L., Chang, W., & Zhang, Y. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1529779 · Cited by 34 · see citing works
“(8) reported that Irisin ameliorates blood glucose homeostasis through aggrandizing fatty acid oxidation and exploiting glucose adopt by the AMPK signaling pathway in a study on diabetic mice.”
BackgroundKooshki, F., Tutunchi, H., Vajdi, M., Karimi, A., Niazkar, H. R., Shoorei, H., & Gargari, B. P. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13462 · Cited by 34 · see citing works
Adipose tissue in older individuals: a contributing factor to sarcopenia
Wang, T., Zhou, D., & Hong, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155998 · Cited by 35 · see citing works
Tsai, C., & Pai, M. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113013 · Cited by 33 · see citing works
Amri, J., Parastesh, M., Sadegh, M., Latifi, S. A., & Alaee, M. (2019) · Physiology International · doi:10.1556/2060.106.2019.24 · Cited by 32 · see citing works
“(40) showed that injection of irisin in type 2 diabetes increased GLUT4 in skeletal muscle and decreased enzymes involved in the gluconeogenesis.”
BackgroundSerum irisin, adropin, and preptin in obese patients 6 months after bariatric surgery
Glück, M., Glück, J., Wiewióra, M., Rogala, B., & Piecuch, J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03998-y · Cited by 31 · see citing works
Pelczyńska, M., Miller‐Kasprzak, E., Piątkowski, M., Mazurek, R., Klause, M., Suchecka, A., Bucoń, M., & Bogdański, P. (2023) · Antioxidants · doi:10.3390/antiox12122046 · Cited by 31 · see citing works
Abdul-Rahman, O., Kristóf, E., Doan‐Xuan, Q., Vida, A., Nagy, L., Horváth, A., Simon, J., Maros, T., Szentkirályi, I., Palotás, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157644 · Cited by 31 · see citing works
Babaei, P., Shirkouhi, S. G., Hoseini, R., & Tehrani, B. S. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0288-z · Cited by 31 · see citing works
“Irisin has been proposed to be secreted by myocytes and adipocytes during exercise [17, 55] and modulates energy expenditure [17] insulin resistance [17] and dyslipidemia [56, 57].”
BackgroundWang, P., Ma, H.-H., Hou, X., Song, L., Song, X.-L., & Zhang, J.-F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.038 · Cited by 31 · see citing works
Irisin and Energy Metabolism and the Role of Irisin on Metabolic Syndrome
Aladag, T., Moğulkoç, R., & Baltacı, A. K. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230411105506 · Cited by 30 · see citing works
Yen, C., Chang, P., Chang, Y., & Lin, P. (2022) · Antioxidants · doi:10.3390/antiox11040725 · Cited by 30 · see citing works
“Irisin assists in utilizing glucose and stimulates fatty acid oxidation in skeletal muscle tissue [10].”
BackgroundGuo, Q., Wei, X., Hu, H., Yang, D., Zhang, B., Fan, X., Liu, J., He, H., Oh, Y., Wu, Q., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.077 · Cited by 30 · see citing works
Li, Y., Wang, B., Shen, J.-D., Bai, M., & Xu, E. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1756349 · Cited by 32 · see citing works
“Therefore, the activation of AMPK has been proposed as an important target for improving insulin sensitivity (Kim et al. 2009; Xin et al. 2016).”
Background
- Authors
- Xin, C., Liu, J., Zhang, J., Zhu, D., Wang, H., Xiong, L., Lee, Y., Ye, J., Lian, K., Xu, C., Zhang, L., Wang, Q., Liu, Y., & Tao, L.
- Affiliations
- Second Artillery General Hospital of Chinese People's Liberation Army (CN)
- Xijing Hospital (CN)
- Corresponding author
- Liu, Y
- Tao, L
- Venue
- International Journal of Obesity
- Published
- 2015-09-25
- Volume
- 40
- Issue
- 3
- Pages
- 443-451
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1923336662
- Cited by
- 248
- References
- 44
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 24 · 2023: 26 · 2022: 28 · 2021: 32 · 2020: 29 · 2019: 19 · 2018: 22 · 2017: 21 · 2016: 12 · 2015: 1
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- irisin, type 2 diabetes, AMPK signaling, fatty acid oxidation, glucose utilization, glucose uptake, GLUT4 translocation, skeletal muscle, gluconeogenesis, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, hepatic glucose metabolism, lipid metabolism, ACACB, UCP1, high-fat diet, glucose tolerance
- MeSH terms
- Animals, Blood Glucose, Diabetes Mellitus, Experimental, Disease Models, Animal, Fatty Acids, Fibronectins, Glucose, Male, Mice, Inbred C57BL, Oxidation-Reduction, Phosphorylation, Signal Transduction, Muscle, Skeletal, Lipid Metabolism, Glucose Transporter Type 4, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review